Health Catalyst, Inc. (NASDAQ:HCAT) Shares Bought by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA grew its position in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 437.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 253,368 shares of the company's stock after purchasing an additional 206,184 shares during the quarter. Massachusetts Financial Services Co. MA owned about 0.44% of Health Catalyst worth $2,346,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Bank of New York Mellon Corp lifted its stake in shares of Health Catalyst by 124.0% during the third quarter. Bank of New York Mellon Corp now owns 854,896 shares of the company's stock worth $8,652,000 after buying an additional 473,323 shares during the period. Principal Financial Group Inc. lifted its stake in shares of Health Catalyst by 38.4% during the third quarter. Principal Financial Group Inc. now owns 25,793 shares of the company's stock worth $261,000 after buying an additional 7,152 shares during the period. Versor Investments LP acquired a new stake in shares of Health Catalyst during the third quarter worth $117,000. Fox Run Management L.L.C. acquired a new stake in shares of Health Catalyst during the third quarter worth $166,000. Finally, Barclays PLC lifted its stake in shares of Health Catalyst by 135.1% during the third quarter. Barclays PLC now owns 53,209 shares of the company's stock worth $538,000 after buying an additional 30,580 shares during the period. 85.00% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms have recently commented on HCAT. KeyCorp reiterated a "sector weight" rating on shares of Health Catalyst in a research note on Wednesday, April 10th. Cantor Fitzgerald restated an "overweight" rating and set a $16.00 target price on shares of Health Catalyst in a research report on Wednesday, April 10th. Evercore ISI decreased their target price on shares of Health Catalyst from $11.00 to $10.00 and set an "outperform" rating for the company in a research report on Friday, February 23rd. Guggenheim upgraded shares of Health Catalyst from a "neutral" rating to a "buy" rating and set a $14.00 target price for the company in a research report on Friday, January 26th. Finally, Wells Fargo & Company decreased their target price on shares of Health Catalyst from $14.00 to $13.00 and set an "overweight" rating for the company in a research report on Friday, May 10th. Three analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $12.18.

Health Catalyst Trading Down 2.1 %

Shares of Health Catalyst stock traded down $0.15 during trading hours on Tuesday, reaching $6.77. The stock had a trading volume of 327,201 shares, compared to its average volume of 634,296. The firm has a market capitalization of $399.63 million, a PE ratio of -3.66 and a beta of 1.32. The stock's 50 day moving average is $6.77 and its 200 day moving average is $8.13. Health Catalyst, Inc. has a twelve month low of $5.45 and a twelve month high of $14.37.

Health Catalyst (NASDAQ:HCAT - Get Free Report) last released its earnings results on Thursday, February 22nd. The company reported ($0.21) EPS for the quarter, topping analysts' consensus estimates of ($0.27) by $0.06. The business had revenue of $75.08 million during the quarter, compared to analysts' expectations of $73.67 million. Health Catalyst had a negative net margin of 35.56% and a negative return on equity of 11.86%. As a group, sell-side analysts predict that Health Catalyst, Inc. will post -0.47 earnings per share for the current year.

Health Catalyst Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.